From: MARK TRAMO

From: MARK TRAMO To: Andy Leuchter <Ma> Bee: " Subject: Re: Invitation to speak at UCLA conference Date: Sun, 06 Aug 2017 18:28:21 +0000 Dear Dr Leuchter, Thank you for your invitation to deliver a talk, participate on a panel, and attend your three-day Art, Neuroscience & Psychiatry Symposium on music and neuroscience this November at the Luskin Conference Center, which I am delighted to accept. I look forward to discussing the details this coming week - might you be available to talk (or meet on campus) this Wednesday Aug 9th? There are a few possibilities for the topic of my talk, including one on neural representations of the "devil's tone" and "perfect fifth" in Western tonal music that I gave at the National Academy of Sciences Koshland Science Museum (http://thesciencenetwork.org/programs/TDLC+Convergence-2014/mark-jude-tramo), and a version of the "Big Ideas" talk I gave at the Aspen Ideas Festival on improving auditory-cognitive development and emotional well-being in critically- ill infants in neonatal ICUs (https://www.aspenideas.org/session/festival- gpening-and-welcome—whats-big-idea). Please visit us at The Institute for Music & Brain Science ft.tp://www.BrainMusic.org) for information and other topics you might find relevant to your Symposium. Please let me know if I might be of help identifying potential speakers for your Symposium - there are several UC faculty in our newly-formed President's Multi-Campus Music Research initiative (UC MERCI) who might be suitable for participation. Yours, Mark On Wed, Aug 2, 2017 at 8:55 PM, Andy Leuchter c wrote: Dear Mark, I am writing at the suggestion of our mutual friend Marco lacoboni. On November 9-11, 2017, we will be hosting our second annual Art, Neuroscience, and Psychiatry Conference at the Luskin Conference Center on the UCLA campus. This conference is jointly sponsored by UCLA and the Los Angeles County Museum of Art (LACMA) and is designed to demonstrate the relevance of neuroscience discoveries not only to the health sciences, but also to the arts and humanities, education, social sciences, and public policy. This extraordinary meeting will bring together over 300 world-class artists, neuroscientists, and clinicians for a three-day educational program. You can see the program for last year's conference at this link: http://www. artneurosciencepsychiatry.com. The conference consists of a series of symposia that include speakers who can address topics from complementary artistic, social, and neuroscience perspectives. One symposium that we are planning to include this year is on music and neuroscience. I am hoping that you will be able to join us for this symposium to speak about your work in therapeutic potential of music. We would ask that you deliver a 20 minute TED-style talk, and participate in a panel discussion at the end of the symposium as well as take questions from the audience. EFTA00456157 I hope that these dates will work with your calendar and that you can accept this invitation. You would be welcome as our guest for the entire conference if you would like attend. I believe that you would find the experience — particularly the opportunity to connect with the leadership of LACMA and with the larger UCLA clinical psychiatry community — highly illuminating and rewarding. Please let me know if you will be available to participate and then we can discuss some of the details further. I look forward to hearing from you. Best regards, Andy Andrew Leuchter, M.D. Professor of Psychiatry and Biobehavioral Sciences Director, TMS Clinical and Research Service Director, Neuromodulation Division Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine at UCLA 760 Westwood Plaza Los Angeles, CA 90024 Mark Jude Tramo, MD PhD Dept of Neurology, David Geffen School of Medicine at UCLA Dept of Musicology, UCLA Herb Alpert School of Music Director, The Institute for Music & Brain Science Co-Director, University of California Multi-Campus Music Research Initiative (UC MERCI) http://www.BrainMusic.org http://merci.ucsd.edu EFTA00456158